vs
Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and Solventum (SOLV). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $2.0B, roughly 1.1× Solventum). CONSTELLIUM SE runs the higher net margin — 5.1% vs 3.2%, a 1.9% gap on every dollar of revenue. CONSTELLIUM SE produced more free cash flow last quarter ($109.0M vs $32.0M).
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
CSTM vs SOLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $2.0B |
| Net Profit | $112.0M | $63.0M |
| Gross Margin | — | 51.4% |
| Operating Margin | 7.5% | 6.3% |
| Net Margin | 5.1% | 3.2% |
| Revenue YoY | — | -3.7% |
| Net Profit YoY | — | 103.2% |
| EPS (diluted) | $0.79 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2B | $2.0B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $1.9B | $2.1B | ||
| Q1 24 | — | $2.0B |
| Q4 25 | $112.0M | $63.0M | ||
| Q3 25 | $88.0M | $1.3B | ||
| Q2 25 | $36.0M | $90.0M | ||
| Q1 25 | $37.0M | $137.0M | ||
| Q4 24 | — | $31.0M | ||
| Q3 24 | — | $122.0M | ||
| Q2 24 | $76.0M | $89.0M | ||
| Q1 24 | — | $237.0M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 54.2% | ||
| Q2 25 | — | 54.4% | ||
| Q1 25 | — | 53.8% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 56.0% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 58.1% |
| Q4 25 | 7.5% | 6.3% | ||
| Q3 25 | 5.8% | 80.6% | ||
| Q2 25 | 2.7% | 9.9% | ||
| Q1 25 | 3.1% | 7.3% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | 5.4% | 11.7% | ||
| Q1 24 | — | 18.9% |
| Q4 25 | 5.1% | 3.2% | ||
| Q3 25 | 4.1% | 60.4% | ||
| Q2 25 | 1.7% | 4.2% | ||
| Q1 25 | 1.9% | 6.6% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | 3.9% | 4.3% | ||
| Q1 24 | — | 11.8% |
| Q4 25 | $0.79 | $0.37 | ||
| Q3 25 | $0.62 | $7.22 | ||
| Q2 25 | $0.25 | $0.51 | ||
| Q1 25 | $0.26 | $0.78 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | $0.51 | $0.51 | ||
| Q1 24 | — | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | $878.0M |
| Total DebtLower is stronger | $1.9B | $5.0B |
| Stockholders' EquityBook value | $952.0M | $5.0B |
| Total Assets | $5.4B | $14.3B |
| Debt / EquityLower = less leverage | 2.00× | 1.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.0M | $878.0M | ||
| Q3 25 | $122.0M | $1.6B | ||
| Q2 25 | $133.0M | $492.0M | ||
| Q1 25 | $118.0M | $534.0M | ||
| Q4 24 | — | $762.0M | ||
| Q3 24 | — | $772.0M | ||
| Q2 24 | — | $897.0M | ||
| Q1 24 | — | $996.0M |
| Q4 25 | $1.9B | $5.0B | ||
| Q3 25 | $2.0B | $5.1B | ||
| Q2 25 | $2.0B | $7.8B | ||
| Q1 25 | $1.9B | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
| Q4 25 | $952.0M | $5.0B | ||
| Q3 25 | $845.0M | $5.0B | ||
| Q2 25 | $780.0M | $3.6B | ||
| Q1 25 | $745.0M | $3.3B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | $796.0M | $2.9B | ||
| Q1 24 | — | $3.9B |
| Q4 25 | $5.4B | $14.3B | ||
| Q3 25 | $5.4B | $14.0B | ||
| Q2 25 | $5.4B | $15.1B | ||
| Q1 25 | $5.2B | $14.5B | ||
| Q4 24 | — | $14.5B | ||
| Q3 24 | — | $14.7B | ||
| Q2 24 | — | $14.6B | ||
| Q1 24 | — | $14.7B |
| Q4 25 | 2.00× | 1.00× | ||
| Q3 25 | 2.34× | 1.03× | ||
| Q2 25 | 2.53× | 2.14× | ||
| Q1 25 | 2.56× | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $218.0M | $95.0M |
| Free Cash FlowOCF − Capex | $109.0M | $32.0M |
| FCF MarginFCF / Revenue | 5.0% | 1.6% |
| Capex IntensityCapex / Revenue | 5.0% | 3.2% |
| Cash ConversionOCF / Net Profit | 1.95× | 1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | $-10.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.0M | $95.0M | ||
| Q3 25 | $99.0M | $76.0M | ||
| Q2 25 | $114.0M | $169.0M | ||
| Q1 25 | $58.0M | $29.0M | ||
| Q4 24 | — | $219.0M | ||
| Q3 24 | — | $169.0M | ||
| Q2 24 | $138.0M | $355.0M | ||
| Q1 24 | — | $442.0M |
| Q4 25 | $109.0M | $32.0M | ||
| Q3 25 | $24.0M | $-21.0M | ||
| Q2 25 | $37.0M | $59.0M | ||
| Q1 25 | $-11.0M | $-80.0M | ||
| Q4 24 | — | $92.0M | ||
| Q3 24 | — | $76.0M | ||
| Q2 24 | $54.0M | $297.0M | ||
| Q1 24 | — | $340.0M |
| Q4 25 | 5.0% | 1.6% | ||
| Q3 25 | 1.1% | -1.0% | ||
| Q2 25 | 1.8% | 2.7% | ||
| Q1 25 | -0.6% | -3.9% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | 2.8% | 14.3% | ||
| Q1 24 | — | 16.9% |
| Q4 25 | 5.0% | 3.2% | ||
| Q3 25 | 3.5% | 4.6% | ||
| Q2 25 | 3.7% | 5.1% | ||
| Q1 25 | 3.5% | 5.3% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | 4.3% | 2.8% | ||
| Q1 24 | — | 5.1% |
| Q4 25 | 1.95× | 1.51× | ||
| Q3 25 | 1.13× | 0.06× | ||
| Q2 25 | 3.17× | 1.88× | ||
| Q1 25 | 1.57× | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | 1.82× | 3.99× | ||
| Q1 24 | — | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
